Managing HCV in Liver Transplant Candidates and Recipients

Expert insight from Leslie B. Lilly, MD, FRCPC, medical director of GI Transplantation from the Toronto General Hospital in Canada, about direct-acting antivirals in the ...

EASL Condemns Cochrane Review of DAA-Based Treatment for HCV

The European Association for the Study of the Liver raises concerns over Cochrane Review of direct acting antivirals for hepatitis C virus.

Predicting Cardiovascular Outcomes in Liver Transplant

Dobutamine stress perfusion echocardiography can detect microvascular perfusion abnormalities that predict cardiovascular outcomes in candidates for liver transplantation.

Tenofovir Prevents Prenatal Transmission of HBV

Women with a high hepatitis B viral load who receive tenofovir during pregnancy have a significantly reduced risk for passing on the virus to their ...

HCV and Type 2 Diabetes

Hepatitis C virus infection may increase the risk for type 2 diabetes, but whether a causal relationship exists is unclear. Screening for type 2 diabetes ...

Latest News

Telbivudine During Early Pregnancy Prevents HBV Transmission

Telbivudine During Early Pregnancy Prevents HBV Transmission

A study showed that telbivudine administered during early and middle pregnancy prevented transmission of hepatitis B virus infection from mother to infants in all participants receiving antiviral treatment.

DAA-Based Eradication of HCV Associated With Improved Glycemic Control

DAA-Based Eradication of HCV Associated With Improved Glycemic Control

Direct-acting antiviral treatment of hepatitis C virus improved glycemic control for patients with type 2 diabetes.

Entecavir/Tenofovir Tx for Chronic HBV Beyond 5 Years Decreases HCC Rate

Entecavir/Tenofovir Tx for Chronic HBV Beyond 5 Years Decreases HCC Rate

Hepatocellular carcinoma decreases beyond year 5 of entecavir/tenofovir therapy in Caucasian patients with chronic hepatitis B virus.

Point-of-Care Test for Active Hepatitis C Virus Infection

Point-of-Care Test for Active Hepatitis C Virus Infection

Point-of-care test was found to have high sensitivity and specificity for detecting HCV RNA in both capillary whole-blood samples collected by finger stick and in plasma samples collected by venipuncture.

HCV Cure Rates High in HIV Coinfection With Integrated Healthcare Program

HCV Cure Rates High in HIV Coinfection With Integrated Healthcare Program

For patients with HCV and HIV coinfection, treatment is effective with standardized nurse/pharmacist support at urban clinics.

Screening for Viral Hepatitis Recommended Before Biologics in RA

Screening for Viral Hepatitis Recommended Before Biologics in RA

The Turkish Society of Rheumatology proposed a guideline of hepatitis screening in patients with rheumatoid arthritis.

HBV Vaccine Prevents Non-Hodgkin Lymphoma in Adolescents

HBV Vaccine Prevents Non-Hodgkin Lymphoma in Adolescents

Universal vaccination against hepatitis B virus infection prevented non-Hodgkin lymphoma in adolescents in Taiwan, an endemic area for hepatitis B virus infection.

Knowledge of HCV Transmission in Opioid-Dependent Pregnant Women

Knowledge of HCV Transmission in Opioid-Dependent Pregnant Women

Most opioid-dependent pregnant patients understand that intravenous drug use is a major transmission modality of hepatitis C virus.

High Rate of SVR Across All HCV Genotypes With Three-Drug Combo

High Rate of SVR Across All HCV Genotypes With Three-Drug Combo

A combination pill of sofosbuvir, velpatasvir, and voxilaprevir is nearly 100% effective in curing hepatitis C in patients whose disease returned after treatment with direct-acting antiviral agents.

FDA, CDC Investigating Hepatitis A Linked to Frozen Tuna

FDA, CDC Investigating Hepatitis A Linked to Frozen Tuna

The FDA and CDC are warning consumers of a hepatitis A virus risk in contaminated frozen tuna.

Sign Up for Free e-newsletters